Cytarabine injections are used primarily to treat certain types of blood cancer, such as acute myeloid leukemia and acute lymphocytic leukemia. They work by inhibiting the growth of cancer cells by affecting DNA and preventing cell division. This medication is given intravenously or sometimes into the spinal fluid under the supervision of a specialist. The dosage is determined based on the patient's condition and response to treatment. It may cause some side effects, such as low blood cells, nausea, vomiting, and general fatigue, which requires close monitoring during treatment.
Cytarabine is an effective medication used as part of a chemotherapy plan to control blood tumors.